Scale up biologics manufacturing
Develop a system to enable scalable, cheap, yeast-based manufacturing of difficult biologics using a continuous in vivo evolution platform, facilitating cheaper medicines, new drugs, and broadening access in low-income countries by enabling manufacturing will less reliance on cold chains.